Endoscopic bronchial valve treatment: Patient selection and special considerations

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 2147-2157

  Eberhardt, Ralf ^a,b   Gompelmann, Daniela ^a,b   Herth, Felix J F ^a,b   Schuhmann, Maren ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b German Center for Lung Research   (Germany)

Author keywords

Collateral ventilation; Lung emphysema; Outcome; Patient selection; Valve treatment

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLLATERAL CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC BRONCHIAL VALVE PLACEMENT; ENDOSCOPIC SURGERY; EXERCISE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERINFLATION; INCIDENCE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG PERFUSION; LUNG RESECTION; LUNG SCINTISCANNING; LUNG VOLUME; MORBIDITY; MORTALITY; PATIENT SELECTION; PNEUMONIA; PNEUMOTHORAX; PULMONARY ARTERY CATHETER; PULMONARY VALVULOPLASTY; QUANTITATIVE ANALYSIS; RESPIRATORY FAILURE; RESPIRATORY TRACT HEMORRHAGE; REVIEW; SMOKING CESSATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; TENSION PNEUMOTHORAX; BRONCHOSCOPY; LUNG VENTILATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY EMPHYSEMA; RISK ASSESSMENT;

BRONCHOSCOPY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PNEUMONECTOMY; PULMONARY EMPHYSEMA; PULMONARY VENTILATION; RISK ADJUSTMENT;

EID: 84944059817     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S63473     Document Type: Review

References (51)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–457.
2. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
3. World Health Organisation. Burden of COPD. Available from: http://www.who.int/respiratory/copd/burden/en/
4. Gillissen A. Herausforderungen, Zukunftsperspektiven, Forschungsansätze. Zur Lage und Zukunft der Pneumologie in Deutschland. Weißbuch Lunge 2014. Herne: FRISCHETEXTE Verlag; 2014. German.
5. O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(2):180–184.
6. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J. 2010;35(3):676–680.
7. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ Jr, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc. 2008;5(4):416–420.
8. Gelb AF, Zamel N, McKenna RJ Jr, Brenner M. Mechanism of short-term improvement in lung function after emphysema resection. Am J Respir Crit Care Med. 1996;154(4 Pt 1):945–951.
9. Gelb AF, McKenna RJ Jr, Brenner M, Fischel R, Baydur A, Zamel N. Contribution of lung and chest wall mechanics following emphysema resection. Chest. 1996;110(1):11–17.
10. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073.
11. Naunheim KS, Wood DE, Krasna MJ, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg. 2006;131(1):43–53.
12. Weder W, Tutic M, Lardinois D, et al. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Ann Thorac Surg. 2009;87(1):229–236; discussion 236–227.
13. Berger RL, Decamp MM, Criner GJ, Celli BR. Lung volume reduction therapies for advanced emphysema: an update. Chest. 2010;138(2):407–417.
14. Kontogianni K, Gerovasili V, Gompelmann D, et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up. Respiration. 2014;88(1):52–60.
15. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012;142(3):574–582.
16. Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration. 2014;88(2):116–125.
17. Herth FJ, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal(R)). Respiration. 2011;82(1):36–45.
18. Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012;39(6):1326–1333.
19. Valipour A, Herth FJ, Eberhardt R, et al. Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study. BMC Pulm Med. 2014;14:190.
20. Magnussen H, Kramer MR, Kirsten AM, et al. Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax. 2012;67(4):302–308.
21. Gompelmann D, Heussel CP, Eberhardt R, et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration. 2012;83(5):400–406.
22. Deslee G, Klooster K, Hetzel M, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014;69(11):980–986.
23. Gompelmann D, Eberhardt R, Herth FJ. Endoscopic lung volume reduction. A European perspective. Ann Am Thorac Soc. 2013;10(6):657–666.
24. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361(9361):931–933.
25. Snell GI, Holsworth L, Borrill ZL, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest. 2003;124(3):1073–1080.
26. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244.
27. Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012;39(6):1334–1342.
28. Ninane V, Geltner C, Bezzi M, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012;39(6):1319–1325.
29. Wood DE, Nader DA, Springmeyer SC, et al. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014;21(4):288–297.
30. Valipour A, Herth FJ, Burghuber OC, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–396.
31. Eberhardt R, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest. 2012;142(4):900–908.
32. Hopkinson NS, Kemp SV, Toma TP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6):1346–1351.
33. Venuta F, Anile M, Diso D, et al. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J. 2012;39(5):1084–1089.
34. Heussel CP, Herth FJ, Kappes J, et al. Fully automatic quantitative assessment of emphysema in computed tomography: comparison with pulmonary function testing and normal values. Eur Radiol. 2009;19(10):2391–2402.
35. Higuchi T, Reed A, Oto T, et al. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax. 2006;61(5):409–413.
36. Eberhardt R, Heussel CP, Kreuter M, Weinheimer O, Herth FJ. Bronchoscopic lung volume reduction in patients with severe homogeneous lung emphysema: a pilot study. Dtsch Med Wochenschr. 2009;134(11):506–510.
37. Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJ. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration. 2010;80(5):419–425.
38. Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–308.
39. Gompelmann D, Ralf E, Slebos DJ, et al. Comparison between Chartis® pulmonary assessment system detection of collateral ventilation vs corelab CT fissure analysis in predicting atelectasis in emphysema patients treated with endobronchial valves. Abstract presented at: ERS Annual Congress; 2012; Vienna, Austria.
40. Koenigkam-Santos M, de Paula WD, Owsijewitsch M, et al. Incomplete pulmonary fissures evaluated by volumetric thin-section CT: semi-quantitative evaluation for small fissure gaps identification, description of prevalence and severity of fissural defects. Eur J Radiol. 2013;82(12):2365–2370.
41. Koenigkam-Santos M, Puderbach M, Gompelmann D, et al. Incomplete fissures in severe emphysematous patients evaluated with MDCT: incidence and interobserver agreement among radiologists and pneumologists. Eur J Radiol. 2012;81(12):4161–4166.
42. Heussel CP, Achenbach T, Buschsieweke C, et al. Quantification of pulmonary emphysema in multislice-CT using different software tools. Rofo. 2006;178(10):987–998.
43. Schuhmann M, Raffy P, Yin Y, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with chartis. Am J Respir Crit Care Med. 2015;191(7):767–774.
44. Aliverti A, Pennati F, Salito C, Woods JC. Regional lung function and heterogeneity of specific gas volume in healthy and emphysematous subjects. Eur Respir J. 2013;41(5):1179–1188.
45. Argula RG, Strange C, Ramakrishnan V, Goldin J. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest. 2013;144(5):1578–1586.
46. Biederer J, Heussel CP, Puderbach M, Wielpuetz MO. Functional magnetic resonance imaging of the lung. Semin Respir Crit Care Med. 2014;35(1):74–82.
47. Eberhardt R, Gerovasili V, Kontogianni K, et al. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration. 2015;89(1):41–48.
48. Hillerdal G, Mindus S. One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series. Respiration. 2014;88(4):320–328.
49. Gompelmann D, Herth FJ, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–491.
50. Gompelmann D, Herth FJF, Heussel CP, Hoffmann H, Dienemann H, Eberhardt R. Pneumothorax nach endoskopischer Ventiltherapie. Pneumologie. 2014;68:V454.
51. Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema-potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–521.